NEUROASPIS
.png)
Product description
A NOVEL & PIONEER INTERVENTION FOR MULTIPLE SCLEROSIS WITH CLINICAL STUDY PHASE III
NEUROASPIS is probably the first patented combination and specially formulated dietary supplement in Europe used for medical purposes in order to support the treatment of MS patients in particular and other related neurodegenerative diseases.
Through a diligent examination of the disease’s modus operandi through a systems medicine approach, the ingredients and their relative concentrations were chosen so the cocktail provides the evident neuro-protective benefits.
NEUROASPIS is a product of more than 10 years of research and clinical development, where the Clinical Studies Phase II and Phase III are published in 2013 and 2022 accordingly in BMJ.
Read more
NEUROASPIS is probably the first patented combination and specially formulated dietary supplement in Europe used for medical purposes in order to support the treatment of MS patients in particular and other related neurodegenerative diseases.
Through a diligent examination of the disease’s modus operandi through a systems medicine approach, the ingredients and their relative concentrations were chosen so the cocktail provides the evident neuro-protective benefits.
NEUROASPIS is a product of more than 10 years of research and clinical development, where the Clinical Studies Phase II and Phase III are published in 2013 and 2022 accordingly in BMJ.
Specifications
| Categories | Specialised Finished ProductsDietary supplements |
|---|---|
| Supplied from | Greece |
| Certifications | Health & Safety |
NEUROASPIS
